Usana Health Sciences Inc Revenue Growth Rates (USNA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Usana Health Sciences Inc   (NYSE: USNA)
 

USNA's Revenue Growth by Quarter and Year

Usana Health Sciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

USNA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter January -
3rd Quarter October -
2nd Quarter July 223.27
1st Quarter April 249.78
FY 473.05

USNAs Annual Revenue
Usana Health Sciences Inc 's Revenue in the fiscal year 2025 $ 924.41 millions
Usana Health Sciences Inc 's Revenue in the fiscal year 2023 $ 854.29 millions
Usana Health Sciences Inc 's Revenue in the fiscal year 2022 $ 997.71 millions
Usana Health Sciences Inc 's Revenue in the fiscal year 2020 $ 1,134.64 millions
Usana Health Sciences Inc 's Revenue in the fiscal year 2019 $ 1,060.90 millions




USNA Revenue second quarter 2026 Y/Y Growth Comment
Usana Health Sciences Inc reported decrease in Revenue in the second quarter 2026 by -5.26% to $ 223.27 millions, from the same quarter in 2025.
The decrease in the second quarter 2026 Usana Health Sciences Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 3.85%.

Looking into second quarter 2026 results within Legal Cannabis industry 15 other companies have achieved higher Revenue growth. While Usana Health Sciences Inc ' s Revenue decline of -5.26% ranks overall at the positon no. 3157 in the second quarter 2026.


USNA Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter January - 5.95 % -3.18 % -3.02 %
3rd Quarter October - 6.45 % -6.05 % -8.55 %
2nd Quarter July -5.26 % 10.88 % -10.65 % -9.88 %
1st Quarter April 0.28 % 9.38 % -8.11 % -9.04 %
FY   - 8.21 % -7.11 % -

Financial Statements
Usana Health Sciences Inc 's second quarter 2026 Revenue $ 223.27 millions USNA's Income Statement
Usana Health Sciences Inc 's second quarter 2025 Revenue $ 235.66 millions Quarterly USNA's Income Statement


USNA Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter January - 6.54 % 7.05 % 3.87 %
3rd Quarter October - -9.67 % -5.92 % -10.53 %
2nd Quarter July -10.61 % -5.39 % -6.67 % -4.02 %
1st Quarter April 10.14 % 16.36 % 3.01 % 8.72 %
FY (Year on Year)   - 8.21 % -7.11 % -


Back to USNA Growth rate Comparisons >> Back to USNA Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #16
Consumer Non Cyclical Sector #128
Overall #3157

Revenue Y/Y Growth Statistics
High Average Low
30.06 % 3.85 % -21.64 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #16
Consumer Non Cyclical Sector #128
Overall #3157
Revenue Y/Y Growth Statistics
High Average Low
30.06 % 3.85 % -21.64 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Usana Health Sciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
18.72 % 1.13 % -18.55 %
 


USNA's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Usana Health Sciences Inc disclosed drop in Revenue from the first quarter by -10.61% to $ 223.27 millions, from $ 249.78 millions achived in the previous reporting period.

But that's not important problem, as Usana Health Sciences Inc 's Revenue generally seem to plunge in this quarter.

Within Legal Cannabis industry 15 other companies have achieved higher Revenue quarter on quarter growth. While Usana Health Sciences Inc 's Revenue growth quarter on quarter, overall rank is 2902.


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #16
Consumer Non Cyclical Sector #115
Overall #2902
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #16
Consumer Non Cyclical Sector #115
Overall #2902
Revenue Q/Q Growth Statistics
High Average Low
18.72 % 1.13 % -18.55 %
 


USNA's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Usana Health Sciences Inc disclosed drop in Revenue from the first quarter by -10.61% to $ 223.27 millions, from $ 249.78 millions achived in the previous reporting period.

But that's not important problem, as Usana Health Sciences Inc 's Revenue generally seem to plunge in this quarter.

Within Legal Cannabis industry 15 other companies have achieved higher Revenue quarter on quarter growth. While Usana Health Sciences Inc 's Revenue growth quarter on quarter, overall rank is 2902.


Usana Health Sciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jul 04 2026)		 12 Months Ending
(Apr 04 2026)		 12 Months Ending
(Jan 03 2026)		 12 Months Ending
(Sep 27 2025)		 12 Months Ending
(Jun 28 2025)
Cumulative Revenue 12 Months Ending $ 912.70 $ 925.09 $ 924.41 $ 911.67 $ 898.78
Y / Y Revenue Growth (TTM) 1.55 % 5.65 % 8.21 % 5.85 % 2.81 %
Year on Year Revenue Growth Overall Ranking # 2010 # 1917 # 1805 # 2142 # 2714
Seqeuential Revenue Change (TTM) -1.34 % 0.07 % 1.4 % 1.43 % 2.64 %
Seq. Revenue Growth (TTM) Overall Ranking # 2010 # 1917 # 1805 # 2142 # 2714


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jul 04 2026 period, Usana Health Sciences Inc 's cumulative twelve months Revenue were $ 913 millions, company would post below average annual Revenue growth of 2.64% year on year, if the fiscal year would end at Jul 04 2026.
A slow-down in the Usana Health Sciences Inc 's Revenue growth from the 875.654% growth in Apr 04 2026.

In the Consumer Non Cyclical sector 80 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1917 to 2010.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 13
Consumer Non Cyclical Sector # 81
Overall # 2336

Revenue TTM Y/Y Growth Statistics
High Average Low
21.39 %
 3.8 %
-15.96 %
(Oct 03 2015)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 82
S&P 500 # 2356
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jul 04 2026 period, Usana Health Sciences Inc 's cumulative twelve months Revenue were $ 913 millions, company would post below average annual Revenue growth of -15.96% year on year, if the fiscal year would end at Jul 04 2026.
A slow-down in the Usana Health Sciences Inc 's Revenue growth from the 875.654% growth in Apr 04 2026.

In the Consumer Non Cyclical sector 80 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1917 to 2010.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 13
Consumer Non Cyclical Sector # 81
Overall # 2336

Revenue TTM Y/Y Growth Statistics
High Average Low
21.39 %
3.8 %
-15.96 %
(Oct 03 2015)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 13
Sector # 82
S&P 500 # 2356




Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
USNA's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jul 04 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jul 04 2026
Hormel Foods Corporation-2.34%$ -2.341 millions
Flowers Foods Inc-4.02%$ -4.015 millions
Coffee Holding Co Inc -5.35%$ -5.353 millions
Limoneira Company-7.73%$ -7.728 millions
Bridgford Foods Corporation-8.94%$ -8.937 millions


About Usana Health Sciences Inc Revenue Growth Rates (USNA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Usana Health Sciences Inc (CIK 896264).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000896264-26-000056
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Usana Health Sciences Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.